1.
Tsuzuki S, Yasuda T, Goto H, Maeda N, Akahane K, Inukai T, Yamamoto H, Karnan S, Ota A, Hyodo T, Konishi H, Hosokawa Y, Kiyoi H, Hayakawa F. BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i&gt;-rearranged acute lymphoblastic leukemia. haematol [Internet]. 2023Feb.1 [cited 2026Feb.8];108(2):394-08. Available from: https://haematologica.org/article/view/haematol.2022.280879